BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6160910)

  • 1. Purification and characterization of carcinoembryonic antigen-related antigens in normal adult feces.
    Kuroki M; Koga Y; Matsuoka Y
    Cancer Res; 1981 Feb; 41(2):713-20. PubMed ID: 6160910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antigenic structures of CEA and CEA-related normal antigens and problems related to the determination of blood CEA concentrations].
    Matsuoka Y; Kuroki M; Koga Y
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):575-84. PubMed ID: 6192762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical differences among carcinoembryonic antigen in tumor tissues and related antigens in meconium and adult feces.
    Matsuoka Y; Kuroki M; Koga Y; Kuriyama H; Mori T; Kosaki G
    Cancer Res; 1982 May; 42(5):2012-8. PubMed ID: 6175402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CEA and related antigens as possible new tumor markers].
    Matsuoka Y
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1754-63. PubMed ID: 6688338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antigenic structure of NCA-2 from meconium and comparison with normal fecal antigen from adult feces and carcinoembryonic antigen from malignant tissues].
    Kuriyama H
    Nihon Geka Gakkai Zasshi; 1983 Apr; 84(4):301-9. PubMed ID: 6201714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope mapping of the carcinoembryonic antigen by monoclonal antibodies and establishment of a new improved radioimmunoassay system.
    Kuroki M; Arakawa F; Higuchi H; Matsunaga A; Okamoto N; Takakura K; Matsuoka Y
    Jpn J Cancer Res; 1987 Apr; 78(4):386-96. PubMed ID: 2438262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological characterization and structural studies of normal fecal antigen-1 related to carcinoembryonic antigen.
    Kuroki M; Shinoda T; Takayasu T; Koga Y; Matsuoka Y
    Mol Immunol; 1982 Mar; 19(3):399-406. PubMed ID: 6178963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of new antigenic fragments related to carcinoembryonic antigen in adult feces.
    Henslee JG; Vachula EJ; Paxton RJ; Matias MS; Shively JE; Rittenhouse HG; Tomita JT
    Cancer Res; 1992 Aug; 52(15):4175-82. PubMed ID: 1379120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolytic release of antigenic fragments corresponding to normal fecal antigen and non-specific cross-reacting antigen from carcinoembryonic antigen.
    Matsuoka Y; Koga Y; Maruta H; Yoshino M; Tsuru E
    Int J Cancer; 1978 May; 21(5):604-10. PubMed ID: 77849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic reactivities of purified preparations of carcinoembryonic antigen (CEA) and related normal antigens using four different radioimmunoassay systems for CEA.
    Kuroki M; Yamaguchi A; Koga Y; Matsuoka Y
    J Immunol Methods; 1983 May; 60(1-2):221-33. PubMed ID: 6406604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic heterogeneity of carcinoembryonic antigen in the circulation defined by monoclonal antibodies against the carbohydrate moiety of carcinoembryonic antigen and closely related antigens.
    Matsunaga A; Kuroki M; Higuchi H; Arakawa F; Takakura K; Okamoto N; Matsuoka Y
    Cancer Res; 1987 Jan; 47(1):56-61. PubMed ID: 2431767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological heterogeneity of carcinoembryonic antigen: purification from meconium of an antigen related to carcinoembryonic antigen.
    Primus FJ; Freeman JW; Goldenberg DM
    Cancer Res; 1983 Feb; 43(2):679-85. PubMed ID: 6401222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["Non-specific cross reacting antigen (NCA)", a tracer of human granulocytes and monocytes].
    Burtin P
    C R Seances Soc Biol Fil; 1979; 173(2):261-9. PubMed ID: 92357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate structures of a normal counterpart of the carcinoembryonic antigen produced by colon epithelial cells of normal adults.
    Fukushima K; Ohkura T; Kanai M; Kuroki M; Matsuoka Y; Kobata A; Yamashita K
    Glycobiology; 1995 Feb; 5(1):105-15. PubMed ID: 7772858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic variants of the nonspecific cross-reacting antigen (NCA).
    Burtin P; Chavanel G; Hendrick JC; Frenoy N
    J Immunol; 1986 Aug; 137(3):839-45. PubMed ID: 2424986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen.
    Ross DD; Gao Y; Yang W; Leszyk J; Shively J; Doyle LA
    Cancer Res; 1997 Dec; 57(24):5460-4. PubMed ID: 9407950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of circulating carcinoembryonic antigen analyzed by sandwich-enzyme immunoassays with different specificities.
    Suzuki N; Kondo K; Tominaga S; Kuroki M; Matsuoka Y
    Cancer Res; 1987 Sep; 47(18):4782-7. PubMed ID: 2441854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of carcinoembryonic antigen-related antigens in normal adult feces.
    Matsuoka Y; Matsuo Y; Sugano K; Ohkura H; Kuroki M; Kuroki M
    Jpn J Cancer Res; 1990 May; 81(5):514-9. PubMed ID: 2166022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.